RABEN DAVID (Chief Medical Officer) sold 9.0% of their position (5.50K shares) of BICARA THERAPEUTICS INC. on the open market
Open‑market sale worth $104.2K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/26/2026ACC: 0001628280-26-021543
Officer· Chief Medical Officer
Since Mar 2026
-5.50K
Net shares
Net seller
$104.2K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
5.50K acquired · 11K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+5.50K
Price / share
$3.79
Trade value
$20.84K
% of position
9.9%
3/25/2026
55.29K→60.79K
Common Stock
Direct
Shares
−5.50K
Price / share
$18.95
Trade value
$104.23K
% of position
9.0%
3/25/2026
60.79K→55.29K
Total
Net shares
+0.00
Net value
-$83.39K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/25/2026 | M · Option Exercise | +5.50K | $3.79 | $20.84K | 9.9% | 55.29K | 60.79K |
| Common Stock Direct | 3/25/2026 | S · Sale | −5.50K | $18.95 | $104.23K | 9.0% | 60.79K | 55.29K |
| Total | +0.00 | -$83.39K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
5.50K shares
Shares
−5.50K
Strike price
3.7898
Held after
47.41K
Exercisable
—
3/25/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock5.50K shares | 3/25/2026 | M · Option Exercise | −5.50K | 3.7898 | — | 47.41K |